Thymosin alpha 1: Started a Phase II trial

Alpha 1 Biomedicals Inc. (ALBM) Product: Thymosin alpha 1 Indication: Patients with chonic hepatitis B who have progressed to end-stage liver disease Status: Started a Phase II trial ...